Adachi, T. & Nakamura, Y. (2019). Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application. Molecules (Basel, Switzerland), 24, 29–42.

Article  Google Scholar 

Byun, J. (2021). Recent Progress and Opportunities for Nucleic Acid Aptamers. Life (Basel, Switzerland), 11, 193.

PubMed  Google Scholar 

Yang, Y., Ren, X., Schluesener, H. J., & Zhang, Z. (2011). Aptamers: selection, modification and application to nervous system diseases. Current medicinal chemistry, 18, 4159–4168.

Article  CAS  PubMed  Google Scholar 

Yazdian-Robati, R., Arab, A., Ramezani, M., Abnous, K., & Taghdisi, S. M. (2017). Application of aptamers in treatment and diagnosis of leukemia. International journal of pharmaceutics, 529, 44–54.

Article  CAS  PubMed  Google Scholar 

Emami, N., Pakchin, P. S., & Ferdousi, R. (2020). Computational predictive approaches for interaction and structure of aptamers. Journal of theoretical biology, 497, 110268.

Article  CAS  PubMed  Google Scholar 

Zhu, G., & Chen, X. (2018). Aptamer-based targeted therapy. Advanced drug delivery reviews, 134, 65–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanwar, J. R., Roy, K., & Kanwar, R. K. (2011). Chimeric aptamers in cancer cell-targeted drug delivery. Critical reviews in biochemistry and molecular biology, 46, 459–477.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kinghorn, A. B., Fraser, L. A., Lang, S., Shiu, S. C. C. & Tanner, J. A. (2017). Aptamer Bioinformatics. International journal of molecular sciences, 18, 2516.

Article  PubMed  PubMed Central  Google Scholar 

Kumar Kulabhusan, P., Hussain, B. & Yüce, M. (2020). Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents. Pharmaceutics, 12, 646

Article  PubMed  PubMed Central  Google Scholar 

Yan, A. C., & Levy, M. (2009). Aptamers and aptamer targeted delivery. RNA biology, 6, 316–320.

Article  CAS  PubMed  Google Scholar 

Nimjee, S. M., White, R. R., Becker, R. C., & Sullenger, B. A. (2017). Aptamers as Therapeutics. Annual review of pharmacology and toxicology, 57, 61–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Radom, F., Jurek, P. M., Mazurek, M. P., Otlewski, J., & Jeleń, F. (2013). Aptamers: molecules of great potential. Biotechnology advances, 31, 1260–1274.

Article  CAS  PubMed  Google Scholar 

Tan, Y., Ma, L., Yang, X., Cheng, Q. N., & Wu, J. F. (2023). Current Status and Challenges of Aptamers Screening and Optimization. Combinatorial chemistry & high throughput screening., 26, 1067–1082.

Article  CAS  Google Scholar 

Wu, Y. X., & Kwon, Y. J. (2016). Aptamers: The “evolution” of SELEX. Methods (San Diego, Calif), 106, 21–28.

Article  CAS  PubMed  Google Scholar 

Sullenger, B. A. (2016). Aptamers Coming of Age at Twenty-Five. Nucleic acid therapeutics, 26, 119.

Article  CAS  PubMed  Google Scholar 

Xu, Y., Yang, X., & Wang, E. (2010). Review: Aptamers in microfluidic chips. Analytica chimica acta, 683, 12–20.

Article  CAS  PubMed  Google Scholar 

Rozenblum, G. T., Lopez, V. G., Vitullo, A. D., & Radrizzani, M. (2016). Aptamers: current challenges and future prospects. Expert opinion on drug discovery, 11, 127–135.

Article  CAS  PubMed  Google Scholar 

Soldevilla, M. M., Hervas, S., Villanueva, H., Lozano, T., Rabal, O., & Oyarzabal, J., et al. (2017). Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA). PloS one, 12, e0185169.

Article  PubMed  PubMed Central  Google Scholar 

Saad, M., & Faucher, S. P. (2021). Aptamers and Aptamer-Coupled Biosensors to Detect Water-Borne Pathogens. Frontiers in microbiology, 12, 643797.

Article  PubMed  PubMed Central  Google Scholar 

Schmitz, F. R. W., Valério, A., de Oliveira, D., & Hotza, D. (2020). An overview and future prospects on aptamers for food safety. Applied microbiology and biotechnology, 104, 6929–6939.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santulli-Marotto, S., Nair, S. K., Rusconi, C., Sullenger, B. & Gilboa, EJCR. (2003). Multivalent RNA aptamers that inhibit CTLA-4 and enhance tumor immunity. Cancer Research, 63, 7483–7489.

CAS  PubMed  Google Scholar 

Zhou, B., Mo, Z., Lai, G., Chen, X., Li, R., & Wu, R., et al. (2023). Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-. Journal of experimental & clinical cancer research: CR, 42, 48.

Article  CAS  PubMed Central  Google Scholar 

Prodeus, A., Abdul-Wahid, A., Fischer, N. W., Huang, E. H., Cydzik, M., & Gariépy, J. (2015). Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers. Molecular therapy Nucleic acids, 4, e237.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gefen, T., Castro, I., Muharemagic, D., Puplampu-Dove, Y., Patel, S., & Gilboa, E. (2017). A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in Mice. Molecular therapy: the journal of the American Society of Gene Therapy, 25, 2280–2288.

Article  CAS  PubMed  Google Scholar 

Gilboa, E., McNamara, 2nd, J., & Pastor, F. (2013). Use of oligonucleotide aptamer ligands to modulate the function of immune receptors. Clinical cancer research: an official journal of the American Association for Cancer Research, 19, 1054–1062.

Article  CAS  PubMed  Google Scholar 

Zhou, G., Wilson, G., Hebbard, L., Duan, W., Liddle, C., & George, J., et al. (2016). Aptamers: A promising chemical antibody for cancer therapy. Oncotarget, 7, 13446–13463.

Article  PubMed  PubMed Central  Google Scholar 

Pratico, E. D., Sullenger, B. A., & Nair, S. K. (2013). Identification and characterization of an agonistic aptamer against the T cell costimulatory receptor, OX40. Nucleic acid therapeutics, 23, 35–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pastor, F., Soldevilla, M. M., Villanueva, H., Kolonias, D., Inoges, S., & de Cerio, A. L., et al. (2013). CD28 aptamers as powerful immune response modulators. Molecular therapy Nucleic acids, 2, e98.

Article  PubMed  PubMed Central  Google Scholar 

Massari, F., Santoni, M., Ciccarese, C., Santini, D., Alfieri, S., & Martignoni, G., et al. (2015). PD-1 blockade therapy in renal cell carcinoma: current studies and future promises. Cancer treatment reviews, 41, 114–121.

Article  CAS  PubMed  Google Scholar 

Eder, J. P., Vande Woude, G. F., Boerner, S. A., & LoRusso, P. M. (2009). Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clinical cancer research: an official journal of the American Association for Cancer Research, 15, 2207–2214.

Article  CAS  PubMed  Google Scholar 

Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., & Ready, N. E., et al. (2015). Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. The New England journal of medicine, 373, 1627–1639.